BRIEF-Ligand Announces Proposed Offering Of $550 Million Of Convertible Senior Notes Due 2031

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated

LGND

0.00

June 22 (Reuters) - Ligand Pharmaceuticals Inc LGND.O:

  • LIGAND ANNOUNCES PROPOSED OFFERING OF $550 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2031

  • LIGAND PHARMACEUTICALS - TO USE PART OF PROCEEDS FOR CONVERTIBLE NOTE HEDGE TRANSACTIONS

  • LIGAND PHARMACEUTICALS - TO USE UP TO $75 MILLION OF PROCEEDS FOR COMMON STOCK REPURCHASE

  • LIGAND PHARMACEUTICALS - INITIAL PURCHASERS GRANTED 13-DAY OPTION TO BUY UP TO $82.5 MILLION ADDITIONAL NOTES

Source text: ID:nGNXc10Y4D

Further company coverage: LGND.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.